Systemic effects of intranasal steroids: an endocrinologist's perspective.
about
Management of osteoporosisTreatment of congestion in upper respiratory diseases.Reduced bone mineral density and radial bone growth in young rabbits treated with dexamethasone eye drops.Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children.The role of intranasal corticosteroids in the management of pediatric allergic rhinitis.Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations.Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis.Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work?Therapeutic management of allergic diseases.Evidence-based management of nasal polyposis by intranasal corticosteroids: from the cause to the clinic.Fluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis.Mometasone implant for chronic rhinosinusitis.Current recommendations and emerging options for the treatment of allergic rhinitis.Topical intranasal corticosteroids and growth velocity in children: a meta-analysis.Current understanding of nasal morphology and physiology as a drug delivery target.Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study.Intranasal Steroid Use for Otitis Media with Effusion: Ongoing Opportunities for Quality Improvement.Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool.Effect of intranasal dexamethasone on endogenous cortisol level and intraocular pressure.Use of intranasal corticosteroids in adenotonsillar hypertrophy.Evaluating the safety of intranasal steroids in the treatment of allergic rhinitis.Simultaneous Bilateral Quadriceps Tendon Rupture following Long-Term Low-Dose Nasal Corticosteroid ApplicationTreatment of adenotonsillar hypertrophy: A prospective randomized trial comparing azithromycin vs. fluticasone.A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial allergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueous suspension-based formulation?A randomized double-blind study to compare the effects of nasal fluticasone and betamethasone on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis.Kinetics of metabolism and degradation of mometasone furoate in rat biological fluids and tissues.Intranasal loteprednol etabonate in healthy male subjects: pharmacokinetics and effects on endogenous cortisol.Safety of intranasal corticosteroid sprays during pregnancy: an updated review.Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.Effects of inhaled steroids on growth, bone metabolism and adrenal function.
P2860
Q24795473-367FBC7B-EA5B-48B3-82A2-C7B15C1865CFQ30481520-BBFF3AFE-AE90-4749-8949-B20C4E355ED3Q31156948-2934D74B-F8CF-415C-8FA6-7AC56B182240Q34647395-223F658F-296E-4058-A692-9A9E523C957FQ36591947-05150F4D-4091-437A-A49D-3471CB4ED0FFQ36755463-06B86CAD-4F49-4058-B8BF-A5A0279FAD63Q37074387-5E5C202E-BA56-4279-BFCC-575240637EA6Q37388073-3CB211B7-7033-4C5E-A795-4A43F0063321Q37550543-1AFDC94A-B8D9-4A04-94AC-C87C3BE83F3AQ37846443-C58197EC-9AF1-45EE-8DBD-342877DC2D73Q37857678-247603FB-6052-4327-9794-2DBCAA5CA36DQ38059869-0CF5F2FB-17A5-41A7-9971-1B226E8838CAQ38250070-F4289D4B-1B2F-406F-9428-9541832E3742Q38264790-12DC4244-D333-4D69-A430-42963AAF8EBFQ38383290-B720F000-A5A9-4685-8E1D-EC43FADF298DQ38731185-785C422C-C7C7-40FF-8562-B858A0AD68DCQ38769045-6C742866-018A-4C0A-AD37-FF8A15777B7EQ38840402-768E0D65-FF65-49C8-B3B5-3B8CA7CC950DQ39014634-48A220D9-EFBD-4DEF-9247-B1167CC573A0Q39151355-3E8F1A2A-6133-4962-A5AE-F4DC256882DEQ40518105-20263989-0E0E-470D-8B94-D6EE06679A9EQ42015968-4E570042-6339-4194-AE8F-112567A48F29Q42120029-ADEEDE55-3885-422F-BFD6-8356338C5DE8Q42677593-86B3C584-11BE-441E-B284-9CAFFF8C49C1Q44242563-8BE2B614-F884-497C-939A-629A5CC73ABDQ44494608-641376D1-E06A-41F1-B255-18FB668040E8Q44854822-12E372BC-C48E-4215-9579-810767F38700Q47430686-25AF6300-39D2-44EF-8E0C-FE0B9CD0B4A3Q50940313-E90D688B-781A-49C7-B7AC-47C6EA52772AQ50948479-E23E1CCA-A46E-4F72-815F-A20559C1418A
P2860
Systemic effects of intranasal steroids: an endocrinologist's perspective.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@ast
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@en
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@nl
type
label
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@ast
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@en
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@nl
prefLabel
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@ast
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@en
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@nl
P356
P1476
Systemic effects of intranasal steroids: an endocrinologist's perspective.
@en
P2093
P304
P356
10.1067/MAI.2000.110038
P407
P433
P577
2000-10-01T00:00:00Z